Froimson Mark 4
4 · Pacira BioSciences, Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Froimson Mark
Director
Transactions
- Award
Common Stock
2024-06-12+5,230→ 13,073 total - Award
Stock Option (Right to Buy)
2024-06-12+12,179→ 12,179 totalExercise: $28.68From: 2025-06-12Exp: 2034-06-12→ Common Stock (12,179 underlying)
Footnotes (1)
- [F1]Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.